Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Fresenius Medical Care reaches ‘agreement in principle’ in FCPA case

Jaclyn Jaeger | February 27, 2019

German healthcare company Fresenius Medical Care disclosed in a financial report that it has reached an “agreement in principle” with U.S. authorities concerning an investigation into possible violations of the Foreign Corrupt Practices Act. Considering incurred and anticipated legal expenses, impairments, and other costs, the provision totals €224 million (U.S. $255 million) as of Dec. 31, 2018.

Fresenius said beginning in 2012 it received certain communications alleging conduct in countries outside the United States concerning potential violations of the FCPA and other anti-bribery laws. “The company’s supervisory board, through its audit and corporate governance committee, conducted investigations with the assistance of independent counsel,” Fresenius said in its Feb. 20 Form 20-F filing.

In a continuing dialogue, Fresenius said...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.